HORN HOWARD (Chief Financial Officer) sold 7.3% of their position (7.07K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $107.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/19/2026ACC: 0001193125-26-425032
Officer· Chief Financial Officer
Since Mar 2026
-7.07K
Net shares
Net seller
$107.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.07K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.07K
Price / share
$15.27
Trade value
$107.90K
% of position
7.3%
10/15/2026
96.30K→89.23K
Total
Net shares
−7.07K
Net value
-$107.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/15/2026 | S · Sale | −7.07K | $15.27 | $107.90K | 7.3% | 96.30K | 89.23K |
| Total | −7.07K | -$107.90K | ||||||
Derivative Transactions0
No derivative transactions reported